Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Julphar
AstraZeneca
Teva
Fuji
Fish and Richardson
Dow
Federal Trade Commission
Deloitte
Citi

Generated: October 21, 2017

DrugPatentWatch Database Preview

CYTOXAN (LYOPHILIZED) Drug Profile

« Back to Dashboard

What is the patent landscape for Cytoxan (lyophilized), and when can generic versions of Cytoxan (lyophilized) launch?

Cytoxan (lyophilized) is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in CYTOXAN (LYOPHILIZED) is cyclophosphamide. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.

Summary for Tradename: CYTOXAN (LYOPHILIZED)

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list136
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CYTOXAN (LYOPHILIZED) at DailyMed

Pharmacology for Tradename: CYTOXAN (LYOPHILIZED)

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-004Aug 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-009Dec 10, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-010Sep 24, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-005Aug 30, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-008Jan 4, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CYTOXAN (LYOPHILIZED)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-010Sep 24, 1985► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-008Jan 4, 1984► Subscribe► Subscribe
Baxter Hlthcare
CYTOXAN (LYOPHILIZED)
cyclophosphamide
INJECTABLE;INJECTION012142-009Dec 10, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Farmers Insurance
Johnson and Johnson
McKinsey
Argus Health
Deloitte
UBS
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot